Clinical Benefits and Safety of Gemtuzumab Ozogamicin in Treating Acute Myeloid Leukemia in Various Subgroups: An Updated Systematic Review, Meta-Analysis, and Network Meta-Analysis

Overview of attention for article published in Frontiers in immunology, August 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 25 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 42,774 followers.

New article: Clinical Benefits and Safety of Gemtuzumab Ozogamicin in Treating Acute Myeloid Leukemia in Various Subgroups: An Updated Systematic Review, Meta-Analysis, and Network Meta-Analysis https://t.co/PaC1Ra8v0D #AML #leusm #hematology https://t.co/

06 Sep 2021

Reply Repost Favourite

Clinical Benefits and Safety of Gemtuzumab Ozogamicin in Treating Acute Myeloid Leukemia in Various Subgroups: An Updated Systematic Review, Meta-Analysis, and Network Meta-Analysis https://t.co/zpDwL0hQC1

17 Aug 2021

Reply Repost Favourite

RT @FrontImmunol: New Research: Clinical Benefits and Safety of Gemtuzumab Ozogamicin in Treating Acute Myeloid Leukemia in Various Subgrou…

16 Aug 2021

Reply Repost Favourite

New Research: Clinical Benefits and Safety of Gemtuzumab Ozogamicin in Treating Acute Myeloid Leukemia in Various Subgroups: An Updated Systematic Review, Meta-Analysis, and Network Meta-Analysis: Background Previous trials demonstrated… https://t.co/6P3p7

16 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.